In 2024, mpox (formerly "monkeypox") re-emerged as a global health threat due to the more severe Clade I strain, underscoring the need for rapid, accessible diagnostics. Traditional polymerase chain reaction (PCR) methods, while effective, demand complex laboratory infrastructure and extended processing times. To address these limitations, this study presents a fast-flow micromixer paper-based analytical device (fmPAD) designed for ultrasensitive, rapid mpox virus (MPXV) detection. The device employs a specially engineered sensing probe with a cytosine-cytosine (C─C) mismatch sequence that hybridizes with the MPXV target, reactivating urease previously inhibited by Ag ions and generating a color change in a pH-sensitive indicator. Enhanced fluid mixing and flow within the fmPAD allow efficient enzymatic reactivation, achieving a linear detection range from 1 to 1000 pm, with a limit of detection (LOD) down to 65 fM. Real viral particles in urine and saliva are also successfully detected at concentrations as low as 5 copies mL without DNA amplification, using a portable colorimeter-representing the lowest LOD among current MPXV DNA sensors. The fmPAD, combined with portable readout technology, enables remote, real-time analysis, offering a practical tool for monitoring and containing the spread of Clade I mpox.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/adhm.202404320 | DOI Listing |
J Med Microbiol
March 2025
NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, UK.
The management of patients with acute infectious diseases can present significant challenges, especially if the causative agent has a propensity for person-to-person transmission. In such cases, effective patient management is dependent on both rapid identification of disease and the provision of necessary medical care while adhering to suitable infection prevention and control measures to reduce the potential for onwards transmission. The UK has operated a defined system for managing patients with high-consequence infectious diseases (HCIDs) since the 1970s, when protocols were first implemented following the first descriptions of several viral haemorrhagic fever diseases, including Marburg virus disease, Lassa fever and Ebola virus disease (EVD).
View Article and Find Full Text PDFEmerg Microbes Infect
March 2025
School of Biomedical Sciences, The University of Hong Kong, 21 Sassoon Road, Pokfulam, Hong Kong.
Mpox virus (MPXV) has to establish efficient interferon (IFN) antagonism for effective replication. MPXV-encoded IFN antagonists have not been fully elucidated. In this study, the IFN antagonism of poxin-schlafen (PoxS) fusion gene of MPXV was characterized.
View Article and Find Full Text PDFHum Vaccin Immunother
December 2025
Department of Research & Development, Yither Biotech Co Ltd, Shanghai, China.
The World Health Organization (WHO) has recently declared another global health emergency due to the rapidly spreading monkeypox (Mpox) outbreak in numerous African countries. To address the unmet need to contain the outbreak using the existing vaccines, this study developed a lyophilization process for an effective, scalable and affordable Mpox mRNA-LNP vaccine candidate to address the global health crisis. A comprehensive evaluation and optimization of the vaccine formulation (the type/concentration of cryoprotectants, the type/concentration of buffer system, as well as the mRNA concentration and reconstitution solvent) and the freeze-drying process parameters (freezing method, temperature, cooling rate and primary/secondary drying conditions) were conducted.
View Article and Find Full Text PDFHealth Sci Rep
March 2025
Grupo de Bibliometría, Evaluación de evidencia y Revisiones Sistemáticas (BEERS), Human Medicine Career Universidad Cientifica del Sur Lima Peru.
Background And Aim: HIV attacks the immune system, leading to AIDS if untreated. Mpox, a zoonotic disease like smallpox, is less severe but poses higher risks for immuno-compromised individuals, especially those with HIV. Effective prevention and treatment are crucial.
View Article and Find Full Text PDFBrief Bioinform
March 2025
Computational Biology and Translational Bioinformatics (CBTB) Laboratory, Department of Biosciences and Bioengineering, Indian Institute of Technology Roorkee, Roorkee 247667, Uttarakhand, India.
The recent pandemics of viral diseases, COVID-19/mpox (humans) and lumpy skin disease (cattle), have kept us glued to viral research. These pandemics along with the recent human metapneumovirus outbreak have exposed the urgency for early diagnosis of viral infections, vaccine development, and discovery of novel antiviral drugs and therapeutics. To support this, there is an armamentarium of virus-specific computational tools that are currently available.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!